JP/ZH: Currently, only the Luminex LTG section and the Service & Support pages regarding Luminex LTG are available in Japanese/Chinese.
08/11/13 - 1:00
The Board of Directors approves the Q3'13 Results (766.57 KB)
29/10/13 - 1:00
DiaSorin signes a 5-year agreement with Roche (432.42 KB)
25/10/13 - 2:00
DiaSorin launches the EHEC Toxins test on stool samples (610.05 KB)
10/10/13 - 2:00
DiaSorin launches the test for IgG to Trypanosoma Cruzi (Chagas) (615.28 KB)
24/09/13 - 2:00
DiaSorin launches the hCG test on its LIAISON XL in the US (599.75 KB)
01/08/13 - 2:00
The Board of Directors approves the results for the H1 '13 (386.67 KB)
24/07/13 - 2:00
DiaSorin launches the new test for Toxoplasmosis on LIAISON IAM (490.89 KB)
11/07/13 - 2:00
DiaSorin obtains the approval of CLIA Hepatitis and Retrovirus tests in Brazil (113.84 KB)
28/06/13 - 2:00
DiaSorin launches the test of Chlamydia Trachomatis IgG and IgA on LIAISON (78.13 KB)
20/06/13 - 2:00
DiaSorin launches the new test for Parvovirus on LIAISON IAM (488.24 KB)
10/05/13 - 2:00
The Board of Directors approves the results for Q1'13 (763.61 KB)
02/05/13 - 2:00
Compensation Commitee-Errata corrige (179.38 KB)
22/04/13 - 2:00
Shareholders' meeting approves FY Results 2012 (57.22 KB)
17/04/13 - 2:00
FDA approves the Aldosterone assay (439.58 KB)
02/04/13 - 2:00
DiaSorin signs an agreement with Seegene (243.64 KB)
08/03/13 - 1:00
The BoD approves FY 2012 results (477.24 KB)
07/03/13 - 1:00
Notification of changes in share capital (46.86 KB)
07/03/13 - 1:00
Notice availability By-Laws (36.87 KB)
07/02/13 - 1:00
Clostridium difficile on LIAISON (available outside the US and Canada only) (79.83 KB)
07/02/13 - 1:00
Notification of changes in share capital (46.89 KB)
07/02/13 - 1:00
Notice availability By-Laws (139.13 KB)
30/01/13 - 1:00
The Board of Directors approves the results for the FY '12 (477.24 KB)
29/01/13 - 1:00
Aldosterone on LIAISON (available outside the US and Canada only) (76.47 KB)
20/12/12 - 1:00
Shareholders' meeting (55.42 KB)
07/11/12 - 1:00
The BoD approves Q3'12 results (280.42 KB)
03/08/12 - 2:00
The BoD approves H1'12 results (279.41 KB)
30/07/12 - 2:00
DiaSorin in India: JV with Trivitron Healthcare (56.16 KB)
27/06/12 - 2:00
Notification of changes in share capital (335.97 KB)
11/05/12 - 2:00
The BoD approves Q1'12 results (122.04 KB)
04/05/12 - 2:00
NorDiag acquisition (88.87 KB)
23/04/12 - 2:00
2011 statutory financial statement approval (182.29 KB)
10/04/12 - 2:00
Measles and Mumps IgM on LIAISON (available outside the US and Canada only) (43.59 KB)
02/04/12 - 2:00
Helicobacter Pylori on stool on LIAISON (available outside the US and Canada only) (43.85 KB)
30/03/12 - 2:00
Financial calendar update (176.51 KB)
22/03/12 - 1:00
Stock options to employees (175.38 KB)
12/03/12 - 1:00
Agreement with Sonic Healthcare on Vitamin D (179.85 KB)
09/03/12 - 1:00
The BoD approves FY 2011 results (357.11 KB)
07/03/12 - 1:00
Notification of changes in share capital (46.84 KB)
17/02/12 - 1:00
DiaSorin became a member of the ISBT (178.96 KB)
09/02/12 - 1:00
Notice of change in share capital (46.97 KB)
02/02/12 - 1:00
FDA clearance for 25 OH Vitamin D on LIAISON (180.35 KB)
27/01/12 - 1:00
2012 Financial calendar update (177.74 KB)
25/01/12 - 1:00
Dividend distribution in June (115.61 KB)
19/01/12 - 1:00
Prize for best Italian Company in R&D in the UK (183.95 KB)
13/01/12 - 1:00
2012 Financial calendar (176.51 KB)
12/01/12 - 1:00